Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease

Overview of attention for article published in Frontiers in immunology, November 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Readers on

mendeley: 38 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 35,545 followers.

New article: Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease https://t.co/1GUImnheyl #livercancer #oncology https://t.co/eXmlh3PnWS

06 Dec 2021

Reply Repost Favourite

RT @GarbineLizeaga: Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease https://t.co/KlxWTdbHNj

17 Nov 2021

Reply Repost Favourite

New Research: Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease: Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a potentially curative therapy for patients suffering from hematological… https://t.co/j2EyNSWmeP

17 Nov 2021

Reply Repost Favourite

Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease https://t.co/KlxWTdbHNj

17 Nov 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.